1
Steroids are still widely used in the treatment of inflammatory bowel diseases.
2
Probiotics have been shown to exert beneficial effects on inflammatory bowel diseases.
3
Intestinal dysbiosis is linked to numerous gastrointestinal disorders, including inflammatory bowel diseases.
4
Actually, probiotic blends and anti-inflammatory drugs represent a weapon against inflammatory bowel diseases.
5
Despite the development of novel therapies, inflammatory bowel diseases remain an innovative treatment challenge.
6
Such persistent modifications could predispose young adults to inflammatory bowel diseases (IBD).
7
Anemia is a common complication of inflammatory bowel diseases.
8
The etiology of inflammatory bowel diseases remains largely unknown.
9
The etiology of inflammatory bowel diseases is only partially explained by the current genetic risk map.
10
Background: Gut bacteria trigger colitis in animal models and are suspected to aggravate inflammatory bowel diseases.
11
Further studies are needed to determine how thalidomide therapy affects long-term progression of inflammatory bowel diseases.
12
Hematopoietic stem cell transplantation has emerged as a new potential therapeutic tool for inflammatory bowel diseases.
13
More than seventy years after their initial characterisation, the aetiology of inflammatory bowel diseases remains elusive.
14
Interestingly, the pattern of IgG anti-endothelial cell subclass observed in the two inflammatory bowel diseases differs.
15
Purpose of review: To consider new data and directions coming from experimental models of inflammatory bowel diseases.
16
Patients with a long-term history of inflammatory bowel diseases show an increased risk of developing colorectal cancers.